{
    "Trade/Device Name(s)": [
        "Hemoglobin FASC Variant Control",
        "extendSURET HbFASC Control"
    ],
    "Submitter Information": "Canterbury Scientific Ltd",
    "510(k) Number": "K053031",
    "Predicate Device Reference 510(k) Number(s)": [
        "K933086",
        "K011389"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "JCM"
    ],
    "Summary Letter Date": "December 7, 2005",
    "Summary Letter Received Date": "October 27, 2005",
    "Submission Date": "October 25, 2005",
    "Regulation Number(s)": [
        "21CFR864.7415"
    ],
    "Regulation Name(s)": [
        "Abnormal Hemoglobin Assay"
    ],
    "Analyte Class(es)": [
        "hematology"
    ],
    "Analyte(s)": [
        "Hemoglobin A (HbA)",
        "Hemoglobin F (HbF)",
        "Hemoglobin S (HbS)",
        "Hemoglobin C (HbC)"
    ],
    "Specimen Type(s)": [],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [],
    "Method(s)/Technology(ies)": [
        "Ion exchange HPLC",
        "Capillary electrophoresis",
        "Cellulose acetate electrophoresis",
        "Agar/agarose gel electrophoresis"
    ],
    "Methodologies": [],
    "Submission Type(s)": [
        "Control"
    ],
    "Document Summary": "FDA 510(k) summary for Hemoglobin FASC Variant Control, a lyophilized control material containing HbA, HbF, HbS, and HbC for use as a position marker in hemoglobin variant analysis.",
    "Indications for Use Summary": "Intended as a position marker for hemoglobin variant analysis methods such as ion exchange HPLC, capillary electrophoresis, and various electrophoresis techniques to assist in identifying common and rare hemoglobin variants.",
    "fda_folder": "Hematology"
}